KT

Katherine Terranova

Consultant at Lumanity

Greater Boston

Overview 

Katherine Terranova is a Life Sciences Professional based in Greater Boston with a Master of Science from Boston University School of Medicine. She has excelled in roles such as Associate at RA Capital Management and Consultant at Lumanity, showcasing strong problem-solving skills and leadership abilities in the life sciences sector. Terranova's career highlights include her experience as a Board Observer at SpyGlass Pharma, Inc. and her role as Head Coach of Women's Club Lacrosse at Boston College, demonstrating a diverse skill set and a proven track record of success in the industry.

Work Experience 

  • Consultant

    2024 - Current

Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes.

  • Head Coach Women's Club Lacrosse

    2023

  • Associate

    2022 - 2023

    - Worked closely with members of the investment team and portfolio companies to deeply understand competitive landscapes and evaluate investment opportunities in all stages from discovery and new company creation through commercialization. - Advised portfolio companies on program and pipeline strategy and served as board observer. - Sourced deals, wrote investment theses, and pitched new ideas to broader investment team. - Performed quantitative analyses to assign fair value and make market projections. - Served as indication expert for front of the eye (glaucoma, cataract, refractive error, corneal diseases), covid vaccines, bacterial vaccines, and gastroesophageal reflux disease. - Attended professional medical conferences (e.g. American Academy of Ophthalmology, World Vaccine Congress).

  • Junior Associate

    2020 - 2022

    - Mapped out indications in several specialties as a member of the Vaccine, General Medicine, and Commercial Teams. - Researched and performed deep diligence on the competitive landscape and future market for a number of ophthalmological diseases.

RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.

  • Board Observer

    2023 - 2023

Spyglass Pharma provides medicine for ophthalmic diseases.

Raised $109,782,347.00 from RA Capital Management, Vertex Ventures HC, New Enterprise Associates, Samsara BioCapital and Vensana Capital.

  • Project Coordinator

    2019 - 2020

    Managed and analyzed quality improvement projects throughout various departments in the hospital for the Clinical Pathways Program.

Briarpatch Pediatrics is a pediatric center that provides health care services to children.

  • Scientific Researcher

    2019 - 2020

    Ran wet-lab experiments to study the Alternative Lengthening of Telomeres pathway utilized by cancer cells with the aim of identifying new therapeutic targets in the Flynn Lab of Genomic Stability and Cancer Therapeutics.

  • Clinical Data Specialist

    2016 - 2018

    - Reviewed ongoing SCAMPs (Standardized Clinical Assessment and Management Plans) cases. - Researched SCAMPs databases to develop case reports and clinical alternatives for the clinical team's review. - Synthesized relevant information from SCAMPs databases. - Prepared case reports to increase efficiency of decision making by clinicians. - Developed report summaries and presented case overviews. - Participated in rounds with the care team, including attending physicians, residents, nurses, nurse practitioners and medical students. - Monitored and maintained accuracy and completeness of SCAMPs databases.

Briarpatch Pediatrics is a pediatric center that provides health care services to children.

  • Clinical Data Management Intern

    2015 - 2015

    - Assisted study leads with data management responsibilities. - Supported Data Management Department through attending meetings, constructing PowerPoint presentations, working on Excel spreadsheets, and performing quality control. - Organized the building of a metrics database for the Data Management Department.

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

Raised $538,040,191.00 from Biotechnology Value Fund and Purdue Pharma.

Articles About Katherine

Relevant Websites